INSYS Therapeutics CEO Discusses Q2 2013 Results - Earnings Call Transcript

Aug. 13, 2013 8:55 PM ETINSYS Therapeutics, Inc. (INSYQ)
SA Transcripts profile picture
SA Transcripts
133.92K Followers

INSYS Therapeutics, Inc. (INSY) Q2 2013 Earnings Call August 13, 2013 11:00 AM ET

Executives

Michael Babich - CEO

Darryl Baker - CFO

Analysts

Jason Butler - JMP Securities

Rohit Vanjani - Oppenheimer

Michael Faerm - Wells Fargo

Operator

Good morning and welcome to INSYS Therapeutics Second Quarter 2013 Operating Results Conference Call. Today’s call is being recorded. The company issued a press release detailing second quarter 2013 financial results this morning. A copy of our earning release can be accessed through the investor relation section at the INSYS’ website at www.insysrx.com. Also, a replay of today’s call will be accessible on the website shortly after we conclude.

On today’s call are Michael Babich, Chief Executive Officer and Darryl Baker, Chief Financial Officer.

The format of today’s call is as follows: Mr. Babich will begin with an overview of recent corporate highlights; Mr. Baker will then provide a summary of financial results for the quarter followed by a Q&A session. Before we get started, I would like to remind everyone that statements made on the conference call today that express a belief, expectation, projection, forecast, and anticipation or intent may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward looking statements are based on information available to INSYS management as of today and we assume no obligation to update these statements as circumstance change. These forward-looking statements may involve a number of risk and uncertainties which may cause the company’s results to differ materially from such statements. Risks and uncertainties could affect forward-looking statements including the failure to successfully launch new products and increase competition. Such risks are outlined in our routine filings with the SEC including our registration statement on Form S1 and our Form 10-Q filings.

Thank you and with that I’ll

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.